TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N-Acetylcysteine Versus L-carnitine in Clomiphene Citrate Resistant Pcos Women. a Randomized Controlled Trial
Brief Summary: N-Acetylcysteine and L-carnitine were used in pcos patients


Options:
A: Arm Label: I.; Type: ACTIVE_COMPARATOR; Interventions: Procedure: intrauterine insemination, Procedure: infertility | Arm Label: II.; Type: ACTIVE_COMPARATOR; Interventions: Procedure: intrauterine insemination, Procedure: infertility | Intervention Type: PROCEDURE; Name: intrauterine insemination; Assigned to Arm(s): I., II. | Intervention Type: PROCEDURE; Name: infertility; Assigned to Arm(s): I., II.
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: pentoxifylline | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: pentoxifylline; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 2
C: Arm Label: N-Acetylcysteine; Type: EXPERIMENTAL; Interventions: Drug: N-Acetylcysteine | Arm Label: L-carnitine; Type: ACTIVE_COMPARATOR; Interventions: Drug: L-carnitine | Intervention Type: DRUG; Name: N-Acetylcysteine; Assigned to Arm(s): N-Acetylcysteine | Intervention Type: DRUG; Name: L-carnitine; Assigned to Arm(s): L-carnitine
D: Arm Label: Berberine; Type: EXPERIMENTAL; Interventions: Drug: Berberine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Berberine; Assigned to Arm(s): Berberine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Demonstration of the Effectiveness of Treatment by Therapeutic Body Wraps in Children and Adolescents Suffering From Autism Spectrum Disorder With Severe Injurious Behavior.
Brief Summary: Severe injurious behaviors in children with autism spectrum disorder are challenging. First line treatment approaches include behavioral techniques but pharmacotherapy is frequently required despite frequent adverse effects in youths.

Therapeutic body wraps has been reported in small series or case reports, but has never been assessed in the context of a randomized controlled trial.

The present study is an exploratory, multicenter, randomized, controlled, open label with blinded outcome assessment (PROBE design) trial of the effect of wet versus dry therapeutic body wraps in children presenting with autism spectrum disorder and severe injurious behavior.


Options:
A: Arm Label: DRY group; Type: ACTIVE_COMPARATOR; Interventions: Other: Dry sheet Therapeutic body wraps | Arm Label: WET Group; Type: EXPERIMENTAL; Interventions: Other: WET sheet Therapeutic body wraps | Intervention Type: OTHER; Name: Dry sheet Therapeutic body wraps; Assigned to Arm(s): DRY group | Intervention Type: OTHER; Name: WET sheet Therapeutic body wraps; Assigned to Arm(s): WET Group
B: Arm Label: LMWH; Type: EXPERIMENTAL; Interventions: Drug: LMWH | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: LMWH; Assigned to Arm(s): LMWH
C: Arm Label: Rivaroxaban; Type: EXPERIMENTAL; Interventions: Drug: Rivaroxaban | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Rivaroxaban; Assigned to Arm(s): Rivaroxaban | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
D: Arm Label: LMWH; Type: EXPERIMENTAL; Interventions: Drug: LMWH | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: LMWH; Assigned to Arm(s): LMWH

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Demonstration of the Effectiveness of Treatment by Therapeutic Body Wraps in Children and Adolescents Suffering From Autism Spectrum Disorder With Severe Injurious Behavior.
Brief Summary: Severe injurious behaviors in children with autism spectrum disorder are challenging. First line treatment approaches include behavioral techniques but pharmacotherapy is frequently required despite frequent adverse effects in youths.

Therapeutic body wraps has been reported in small series or case reports, but has never been assessed in the context of a randomized controlled trial.

The present study is an exploratory, multicenter, randomized, controlled, open label with blinded outcome assessment (PROBE design) trial of the effect of wet versus dry therapeutic body wraps in children presenting with autism spectrum disorder and severe injurious behavior.


Options:
A: Arm Label: Rivaroxaban; Type: EXPERIMENTAL; Interventions: Drug: Rivaroxaban | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Rivaroxaban; Assigned to Arm(s): Rivaroxaban | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
B: Arm Label: DRY group; Type: ACTIVE_COMPARATOR; Interventions: Other: Dry sheet Therapeutic body wraps | Arm Label: WET Group; Type: EXPERIMENTAL; Interventions: Other: WET sheet Therapeutic body wraps | Intervention Type: OTHER; Name: Dry sheet Therapeutic body wraps; Assigned to Arm(s): DRY group | Intervention Type: OTHER; Name: WET sheet Therapeutic body wraps; Assigned to Arm(s): WET Group
C: Arm Label: LMWH; Type: EXPERIMENTAL; Interventions: Drug: LMWH | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: LMWH; Assigned to Arm(s): LMWH
D: Arm Label: LMWH; Type: EXPERIMENTAL; Interventions: Drug: LMWH | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: LMWH; Assigned to Arm(s): LMWH

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Shortened Time Interval to Postpartum Visit in Improving Postpartum Attendance
Brief Summary: Due to potential to improve family planning, clinicians are increasingly interested in shortening the time to postpartum visits, but lack an evidence base to change policy.There are no studies that have examined the effectiveness of shortened interval to postpartum visit on attendance rate, contraception use, and rapid repeat of pregnancy (RROP). With this research, the investigators propose to conduct a randomized controlled trial (RCT) to examine the effect of reduced time interval to postpartum visit (3-4 weeks rather than 6-8 weeks) on postpartum visit attendance rate, contraceptive use, and RROP.


Options:
A: Intervention Type: BEHAVIORAL; Name: Home Nurse Visit; Assigned to Arm(s): N/A
B: Arm Label: Postpartum Visit 3-4 Weeks; Type: EXPERIMENTAL; Interventions: Behavioral: Postpartum Visit 3-4 Weeks | Arm Label: Postpartum Visit 6-8 Weeks; Type: EXPERIMENTAL; Interventions: Behavioral: Postpartum Visit 6-8 Weeks | Intervention Type: BEHAVIORAL; Name: Postpartum Visit 3-4 Weeks; Assigned to Arm(s): Postpartum Visit 3-4 Weeks | Intervention Type: BEHAVIORAL; Name: Postpartum Visit 6-8 Weeks; Assigned to Arm(s): Postpartum Visit 6-8 Weeks
C: Arm Label: New breastfeeding programme; Type: EXPERIMENTAL; Interventions: Other: New Breastfeeding Counselling | Arm Label: Treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment as usual | Intervention Type: OTHER; Name: New Breastfeeding Counselling; Assigned to Arm(s): New breastfeeding programme | Intervention Type: OTHER; Name: Treatment as usual; Assigned to Arm(s): Treatment as usual
D: Arm Label: Durham Connects Eligible; Type: EXPERIMENTAL; Interventions: Other: Durham Connects | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Durham Connects; Assigned to Arm(s): Durham Connects Eligible

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Shortened Time Interval to Postpartum Visit in Improving Postpartum Attendance
Brief Summary: Due to potential to improve family planning, clinicians are increasingly interested in shortening the time to postpartum visits, but lack an evidence base to change policy.There are no studies that have examined the effectiveness of shortened interval to postpartum visit on attendance rate, contraception use, and rapid repeat of pregnancy (RROP). With this research, the investigators propose to conduct a randomized controlled trial (RCT) to examine the effect of reduced time interval to postpartum visit (3-4 weeks rather than 6-8 weeks) on postpartum visit attendance rate, contraceptive use, and RROP.


Options:
A: Arm Label: Enhanced Intervention; Type: EXPERIMENTAL; Interventions: Other: Enhanced Intervention | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Enhanced Intervention; Assigned to Arm(s): Enhanced Intervention | Intervention Type: OTHER; Name: Intervention; Assigned to Arm(s): Intervention
B: Arm Label: Postpartum Visit 3-4 Weeks; Type: EXPERIMENTAL; Interventions: Behavioral: Postpartum Visit 3-4 Weeks | Arm Label: Postpartum Visit 6-8 Weeks; Type: EXPERIMENTAL; Interventions: Behavioral: Postpartum Visit 6-8 Weeks | Intervention Type: BEHAVIORAL; Name: Postpartum Visit 3-4 Weeks; Assigned to Arm(s): Postpartum Visit 3-4 Weeks | Intervention Type: BEHAVIORAL; Name: Postpartum Visit 6-8 Weeks; Assigned to Arm(s): Postpartum Visit 6-8 Weeks
C: Intervention Type: BEHAVIORAL; Name: Home Nurse Visit; Assigned to Arm(s): N/A
D: Arm Label: experimental group; Type: EXPERIMENTAL; Interventions: Behavioral: breastfeeding education, Behavioral: personal hygiene education, Behavioral: nutrition education, Behavioral: fatigue education, Behavioral: sleep education, Behavioral: pilates exercises education | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: breastfeeding education; Assigned to Arm(s): experimental group | Intervention Type: BEHAVIORAL; Name: personal hygiene education; Assigned to Arm(s): experimental group | Intervention Type: BEHAVIORAL; Name: nutrition education; Assigned to Arm(s): experimental group | Intervention Type: BEHAVIORAL; Name: fatigue education; Assigned to Arm(s): experimental group | Intervention Type: BEHAVIORAL; Name: sleep education; Assigned to Arm(s): experimental group | Intervention Type: BEHAVIORAL; Name: pilates exercises education; Assigned to Arm(s): experimental group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: NMDA Receptor Modulation for Hyperarousal in PTSD
Brief Summary: This Phase 1b study examines the safety and efficacy of parenterally-administered lanicemine in a parallel-arm, randomized, double-blind, placebo-controlled trial in adult patients (N=24) with significant PTSD symptoms and elevated anxiety potentiated startle (APS). Investigator hypothesize that lanicemine (100 mg) displays a normalization of APS following three infusions over 5 non-consecutive days. If target engagement is demonstrated and the drug is safe and tolerable in this patient population, investigator will proceed to a larger POC study.


Options:
A: Arm Label: Prolonged Exposure (CBT); Type: EXPERIMENTAL; Interventions: Procedure: Cognitive Behavioral Therapy | Arm Label: Cognitive Therapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cognitive Therapy | Arm Label: SSRI (escitalopram); Type: EXPERIMENTAL; Interventions: Drug: Escitalopram | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Waiting List; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): Prolonged Exposure (CBT) | Intervention Type: PROCEDURE; Name: Cognitive Therapy; Assigned to Arm(s): Cognitive Therapy | Intervention Type: DRUG; Name: Escitalopram; Assigned to Arm(s): SSRI (escitalopram) | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Drug: Lanicemine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Lanicemine; Assigned to Arm(s): Treatment | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Oxytocin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: hydrocortisone sodium succinate | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: hydrocortisone sodium succinate; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of a Novel Smartphone Application on Postpartum Weight Loss and Breastfeeding Rates Among Low-income, Urban Women
Brief Summary: Breastfed babies have significant health benefits extending beyond infancy, including lower rates of childhood obesity and infection. Mothers who breastfeeding also have health benefits, including increased rates of postpartum weight loss. Low-income women are less likely to breastfeed comparatively; this disparity may be due to misconceptions about breastfeeding benefits or poor social support. Based on survey results and focus groups of low-income women, the investigators designed a novel smart-phone application to confront barriers women perceived prevented them from breastfeeding and propose the first-ever randomized controlled trial describing the impact a smart phone app has on postpartum weight loss and breastfeeding rates among low-income women.


Options:
A: Arm Label: eHealth Intervention; Type: EXPERIMENTAL; Interventions: Other: eHealth Breastfeeding Co-parenting Resource | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: eHealth Breastfeeding Co-parenting Resource; Assigned to Arm(s): eHealth Intervention
B: Arm Label: BreastFeeding Friend (BFF); Type: EXPERIMENTAL; Interventions: Other: BreastFeeding Friend (BFF) | Arm Label: dummy app; Type: PLACEBO_COMPARATOR; Interventions: Other: dummy app | Intervention Type: OTHER; Name: BreastFeeding Friend (BFF); Assigned to Arm(s): BreastFeeding Friend (BFF) | Intervention Type: OTHER; Name: dummy app; Assigned to Arm(s): dummy app
C: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Simulation breastfeeding education | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Simulation breastfeeding education; Assigned to Arm(s): Intervention Group
D: Arm Label: Family groups; Type: EXPERIMENTAL; Interventions: Behavioral: Family groups | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Family groups; Assigned to Arm(s): Family groups

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Integrating Counseling to Transform HIV Family Planning Services
Brief Summary: This 3-arm cluster randomized controlled trial (RCT) will compare (1) a comprehensive family planning (FP) program that incorporates a structured, multi-component safer conception counseling (SCC) intervention (SCC1) versus (2) a SCC training workshop for FP nurses (SCC2; less intensive and mimics approach used by Ugandan Ministry of Health (MoH) to integrate new services), and (3) existing FP services (usual care) at 9 HIV clinics (3 per arm) operated by The AIDS Support Organization (TASO) Uganda.


Options:
A: Arm Label: Telephone genetic counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone Genetic Counseling | Arm Label: In-person genetic counseling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: In-Person Genetic Counseling | Intervention Type: BEHAVIORAL; Name: Telephone Genetic Counseling; Assigned to Arm(s): Telephone genetic counseling | Intervention Type: BEHAVIORAL; Name: In-Person Genetic Counseling; Assigned to Arm(s): In-person genetic counseling
B: Arm Label: FRAX + Decision Aid; Type: EXPERIMENTAL; Interventions: Behavioral: FRAX + Decision Aid | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: FRAX estimated fracture risk; Type: EXPERIMENTAL; Interventions: Behavioral: FRAX estimated fracture risk | Intervention Type: BEHAVIORAL; Name: FRAX + Decision Aid; Assigned to Arm(s): FRAX + Decision Aid | Intervention Type: BEHAVIORAL; Name: FRAX estimated fracture risk; Assigned to Arm(s): FRAX estimated fracture risk
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Heart to Heart (Web-Based Decision Aid), Behavioral: Physician Education Session | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Heart to Heart (Web-Based Decision Aid); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Physician Education Session; Assigned to Arm(s): 1
D: Arm Label: SCC1--high intensity supervision; Type: EXPERIMENTAL; Interventions: Behavioral: safer conception counseling | Arm Label: SCC2-- low intensity supervision; Type: EXPERIMENTAL; Interventions: Behavioral: safer conception counseling | Arm Label: Usual care family planning services; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: safer conception counseling; Assigned to Arm(s): SCC1--high intensity supervision, SCC2-- low intensity supervision

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Intensive Cognitive Rehabilitation in Subacute Stroke Patient
Brief Summary: Early stroke rehabilitation is known to be an effective and essential therapy in gaining functional independence and preventing complications. However, there was no consensus of proper amount of cognitive rehabilitation in stroke patients. In this study, the investigators assess the effects of the intensive cognitive rehabilitation during subacute phase to improve cognitive function at 6 months after onset in patients with first-ever strokes.


Options:
A: Arm Label: Variable high-intensity Training; Type: EXPERIMENTAL; Interventions: Behavioral: exercise | Arm Label: Variable low-intensity training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: exercise | Arm Label: Constant High Intensity Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: exercise | Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): Constant High Intensity Training, Variable high-intensity Training, Variable low-intensity training
B: Arm Label: ASAP; Type: EXPERIMENTAL; Interventions: Behavioral: Accelerated Skill Acquisition Program (ASAP) | Arm Label: DEUCC; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dose-Equivalent Usual & Customary Care - DEUCC | Arm Label: UCC; Type: OTHER; Interventions: Behavioral: Usual and Customary Care - UCC | Intervention Type: BEHAVIORAL; Name: Accelerated Skill Acquisition Program (ASAP); Assigned to Arm(s): ASAP | Intervention Type: BEHAVIORAL; Name: Dose-Equivalent Usual & Customary Care - DEUCC; Assigned to Arm(s): DEUCC | Intervention Type: BEHAVIORAL; Name: Usual and Customary Care - UCC; Assigned to Arm(s): UCC
C: Arm Label: Higher-intensity RT group; Type: EXPERIMENTAL; Interventions: Device: RT, Behavioral: Conventional rehabilitation (CR) | Arm Label: Lower-intensity RT group; Type: EXPERIMENTAL; Interventions: Device: RT, Behavioral: Conventional rehabilitation (CR) | Arm Label: Conventional rehabilitation (CR) group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional rehabilitation (CR) | Intervention Type: DEVICE; Name: RT; Assigned to Arm(s): Higher-intensity RT group, Lower-intensity RT group | Intervention Type: BEHAVIORAL; Name: Conventional rehabilitation (CR); Assigned to Arm(s): Conventional rehabilitation (CR) group, Higher-intensity RT group, Lower-intensity RT group
D: Arm Label: Intensive group; Type: EXPERIMENTAL; Interventions: Procedure: Cognitive rehabilitation | Arm Label: Conventional group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cognitive rehabilitation | Intervention Type: PROCEDURE; Name: Cognitive rehabilitation; Assigned to Arm(s): Conventional group, Intensive group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Intensive Cognitive Rehabilitation in Subacute Stroke Patient
Brief Summary: Early stroke rehabilitation is known to be an effective and essential therapy in gaining functional independence and preventing complications. However, there was no consensus of proper amount of cognitive rehabilitation in stroke patients. In this study, the investigators assess the effects of the intensive cognitive rehabilitation during subacute phase to improve cognitive function at 6 months after onset in patients with first-ever strokes.


Options:
A: Arm Label: r-TMS Group; Type: EXPERIMENTAL; Interventions: Device: r-TMS | Arm Label: Sham Group; Type: SHAM_COMPARATOR; Interventions: Device: SHAM | Intervention Type: DEVICE; Name: r-TMS; Assigned to Arm(s): r-TMS Group | Intervention Type: DEVICE; Name: SHAM; Assigned to Arm(s): Sham Group
B: Arm Label: Labyrinth training, then Standard training; Type: EXPERIMENTAL; Interventions: Device: Adaptive computer game training | Arm Label: Standard training, then Labyrinth training; Type: EXPERIMENTAL; Interventions: Device: Standard computerized training | Intervention Type: DEVICE; Name: Adaptive computer game training; Assigned to Arm(s): Labyrinth training, then Standard training | Intervention Type: DEVICE; Name: Standard computerized training; Assigned to Arm(s): Standard training, then Labyrinth training
C: Arm Label: Intensive group; Type: EXPERIMENTAL; Interventions: Procedure: Cognitive rehabilitation | Arm Label: Conventional group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Cognitive rehabilitation | Intervention Type: PROCEDURE; Name: Cognitive rehabilitation; Assigned to Arm(s): Conventional group, Intensive group
D: Arm Label: Sham tDCS plus RTP; Type: SHAM_COMPARATOR; Interventions: Device: Sham tDCS | Arm Label: Active tDCS plus RTP; Type: ACTIVE_COMPARATOR; Interventions: Device: Active tDCS | Intervention Type: DEVICE; Name: Sham tDCS; Assigned to Arm(s): Sham tDCS plus RTP | Intervention Type: DEVICE; Name: Active tDCS; Assigned to Arm(s): Active tDCS plus RTP

Answer: C